Table 2.

Outcomes according to ELN-2022 risk groups.

ELN-2022 risk group	CR rate [%]	p	5 y RFS [%] (95% CI)	p	5 y OS [%] (95% CI)	p
All patients
Favorable	73	<0.0001	52.4 (46.6–58.9)	<0.0001	54.6 (49.6–60.0)	<0.0001
Intermediate	66		31.5 (25.6–38.8)		34.2 (29.2–40.1)
Adverse	45		15.6 (11.3–21.7)		14.8 (11.8–18.5)
Patients < 60a
Favorable	75	<0.0001	60.2(53.2–68.0)	0.0002	62.2 (56.2–68.8)	0.006
Intermediate	67		41.3 (33.4–51.2)		44.2 (37.4–52.2)
Adverse	46		29.1 (20.9–40.7)		25.1 (19.5–32.3)
Patients ≥ 60a
Favorable	70	<0.0001	37.0 (28.1–48.8)	0.0002	40.6 (32.8–50.2)	0.008
Intermediate	64		16.1 (4.2–26.9)		19.4 (13.4–28.1)
Adverse	43		5.6 (2.3–12.4)		7.6 (4.9–11.7)